ian-musgrave-1305864960

Ian Musgrave

Molecular Pharmacologist
I am a molecular pharmacologist who works at the University of Adelaide, Australia. I have a broad interest in the understanding of how surface receptors can modulate neuronal function and survival, as well as interests in natural product pharmacology and drug design. As well I am interested in evolutionary biology, science communication (committee member of SA Science Communicators) and am an avid amateur astronomer. My astronomy blog is astroblog.I did postdoctoral work in the Institute of Pharmacology at the Free University of Berlin in 1991-1994, returning to Australia in 1994. I have collaborated with Professor John Carver, Dr. Scot Smid and Professor Colin Barrow on using natural products to attack the neurodegeneration process in Alzheimer’s Disease. I was recently elected as convenor of the Toxicology Special Interest Group of the Australasian Society for Pharmacology and Toxicology. I am also collaborating with Professor Roger Byard on the forensic implications of herbal medicines. I have held NH&MRC funding and currently hold ARC funding.

More from this expert

The Australian National Health and Medical research Council (NHMRC) has today released draft guidelines for acceptable levels of per- and polyfluoroalkyl substances, or PFAS, in drinking water.

Clinical Articles iconClinical Articles

Last week, the Therapeutic Goods Administration (TGA) released its safety review of seven active ingredients commonly used in sunscreens.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

Peanut Allergy

Tuesday 17th March, 7pm - 9pm AEDT

Speaker

Dr Sam Mehr

Paediatric Allergist, Immunologist & Immunopathologist; Royal Children’s Hospital; Epworth Hospital, Melbourne

Peanut allergy incidence among children is increasing, but there's more to managing it than just avoidance and adrenalin. Join Dr Sam Mehr as he covers the full spectrum of peanut allergy management options.